Page last updated: 2024-12-07
4-azidoaniline
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
4-azidoaniline: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 84674 |
CHEMBL ID | 3236180 |
SCHEMBL ID | 13449658 |
MeSH ID | M0192697 |
Synonyms (11)
Synonym |
---|
14860-64-1 |
4-azidoaniline |
einecs 238-929-0 |
benzenamine, 4-azido- |
doi:10.14272/ssmvdpyhlfeaje-uhfffaoysa-n |
10.14272/SSMVDPYHLFEAJE-UHFFFAOYSA-N |
CHEMBL3236180 |
SSMVDPYHLFEAJE-UHFFFAOYSA-N |
SCHEMBL13449658 |
DTXSID80164033 |
EN300-263940 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (1)
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID1126206 | Inhibition of human recombinant SIRT2 using Fluor-de-Lys as substrate at 10 uM incubated for 60 mins prior to substrate addition measured after 60 mins by fluorometric analysis | 2014 | Bioorganic & medicinal chemistry letters, Apr-15, Volume: 24, Issue:8 | Identification of novel SIRT2-selective inhibitors using a click chemistry approach. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (9)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 5 (55.56) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 27.36
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (27.36) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 9 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |